Observations on the effect of a folic-acid antagonist on transplantable lymphoid leukemias in mice.

No abstract is available for this paper.

• Publication year

  1949

• Venue

  Journal of the National Cancer Institute

• Publication date

  1949-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1093/JNCI/10.1.179PMID 18143260
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Aminopterin, a folic acid antagonist, in the treatment of leukemia.

  1949cited by this paper
• The effect of folic‐acid derivatives on sarcoma 180

  1949cited by this paper
• Use of folic acid antagonist in chronic leukemia.

  1949cited by this paper
• The use of folic acid antagonists in the treatment of acute and subacute leukemia.

  1949cited by this paper
• Studies on the chemotherapy of leukemia. II. The effect of 4‐amino‐pteroylglutamic acid and 4‐amino‐n10‐methyl‐pteroylglutamic acid on transplanted mouse leukemia

  1949cited by this paper
• Some observations on the effect of folic acid antagonists on acute leukemia and other forms of incurable cancer.

  1949cited by this paper
• Studies on the mechanism of action of the nitrogen and sulfur mustards in vivo.

  1948cited by this paper
• Response of Normal and Malignant Lymphoid Tissue to Non Specific Tissue Damage∗

  1948cited by this paper
• Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid.

  1948cited by this paper
• Interference With Estrogen-induced Tissue Growth in the Chick Genital Tract by a Folic Acid Antagonist.

  1948cited by this paper
• Urethane (Ethyl Carbamate) Therapy in Spontaneous Leukemias in Mice.

  1947cited by this paper
• The Cytological Action of Ethylcarbamate (Urethane) and Other Carbamic Esters in Normal and Leukaemic Mice, and in Rabbits

  1947cited by this paper
• The Action of Pteroylglutamic Conjugates on Man.

  1947cited by this paper
• d (--) Methylfolic acid displacing agent for folic acid.

  1947cited by this paper
• Lesions of chronic thiamine deficiency in mice.

  1947cited by this paper

• Early life cancer and chemotherapy lead to cognitive deficits related to alterations in microglial-associated gene expression in prefrontal cortex.

  2023cites this paper
• Murine Models of Acute Myeloid Leukemia

  2022cites this paper
• Engineering Stromal Heterogeneity in Cancer.

  2021cites this paper
• ASSESSMENT OF DISSIMILARITY IN AMETHOPTERIN MEDIUM HEREDITY DISCLOSES TGFBR2 CONNECTED BY MEANS OF FORECAST OF ESTRADIOL RECEPTOR

  2020cites this paper
• EVALUATION OF DIFFERENCE IN AMETHOPTERIN CONDUIT HEREDITY DISCLOSES TGFBR2 TO BE CONNECTED BY MEANS OF PREDICTION OF ESTRADIOL RECEPTOR NEGATIVE CHEST TUMOR FOLLOWING THERAPY

  2020cites this paper
• Insights towards a better understanding and novel treatment modalities of Toxoplasmosis

  2019cites this paper
• Data-Driven HTS Strategies for Selection of Drug Combinations and 3D Models for Physiologically Relevant Drug Discovery

  2019cites this paper
• A Critical Review of Animal Models Used in Acute Myeloid Leukemia Pathophysiology

  2019cites this paper
• Chemotherapy over the Years

  2018cites this paper
• Design, synthesis and biological evaluation of nucleotide pro-drugs centred on clinically active anticancer nucleosides

  2016cites this paper
• Chronology of Anticancer Drug Development

  2016cites this paper
• Using genetics to identify epigenetic and signal transduction targets in cancer

  2016cites this paper
• Antiproliferative activities of halogenated pyrrolo[3,2-d]pyrimidines.

  2015cites this paper
• N-Farnesyloxy-norcantharimide and N-farnesyl-norcantharimide inhibit the progression of leukemia and increase survival days in a syngeneic mouse leukemia model

  2015cites this paper
• Antiproliferative activities of halogenated thieno[3,2-d]pyrimidines.

  2014cites this paper
• Targeting B Cell Acute Lymphoblastic Leukemia with Oncolytic Virotherapy and Histone Deacetylase Inhibition

  2014cites this paper
• ANIMAL MODELS OF CANCER: A REVIEW

  2013cites this paper
• Identification of tumorigenic and therapeutically actionable mutations in transplantable mouse tumor cells by exome sequencing

  2013cites this paper
• Animal models of leukemia: any closer to the real thing?

  2013cites this paper
• Mesenchymal stromal cells primed with Paclitaxel attract and kill leukaemia cells, inhibit angiogenesis and improve survival of leukaemia‐bearing mice

  2013cites this paper
• Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy

  2013cites this paper
• Synthetic and green vegetable isothiocyanates target red blood leukemia cancers.

  2012cites this paper
• Murine Models of B-Cell Lymphomas: Promising Tools for Designing Cancer Therapies

  2012cites this paper
• Transplantable Syngeneic Rodent Tumors: Solid Tumors in Mice

  2011cites this paper
• Murine L1210 and P388 Leukemias

  2011cites this paper
• Preclinical Tumor Response End Points

  2011cites this paper
• Human Tumor Xenograft Efficacy Models

  2011cites this paper
• The sign or " target " for pages apparently lacking from the document photographed is

  2011cites this paper
• Bioluminescence Imaging of Luciferase Transgenes in Tumor Metastases Models

  2011cites this paper
• 2 Murine L 1210 and P 388 Leukemias

  2010cites this paper
• Tumor Stem Cells and Malignant Cells, One and the Same

  2009cites this paper
• The proliferation kinetics of L 1210 ascites tumour.

  2009cites this paper
• Teratogenig Effects of Tumour‐Inhibiting Chemicals in the Foetal Rat

  2008cites this paper
• A history of cancer chemotherapy.

  2008cites this paper
• Tumor Models for Effi cacy Determination

  2008cites this paper
• IMMUNOTHERAPY OF MURINE LEUKEMIA. VII. PREVENTION OF PASSIVE SERUM THERAPY FRIEND LEUKEMIA VIRUS-INDUCED IMMUNOSUPPRESSION BY

  2006cites this paper
• Effects of Combinations of Antileukemic Agents on an Acute Lymphocytic Leukemia of Mice*

  2006cites this paper
• Tumor models for efficacy determination

  2006cites this paper
• Combined Effects of Chemotherapy and Immunity against Leukemia L1210 in DBA/2 Mice'

  2006cites this paper
• Effects of Combinations of Antileukemic Agents on an Acute Lymphocytic Leukemia of Mice*

  2006cites this paper
• Isolation and Characterization of Subclones of L 1210 Murine Leukemia with Different Sensitivities to Various Cytotoxic Agents 1

  2006cites this paper
• Effects of A-Methopterin on Nucleic Acid Synthesis in Leukemic Spleen

  2006cites this paper
• Structural differences between sensitive and resistant L1210 cells.

  2006cites this paper
• A single i.v. injection of viable Ll2lO cells produced a classical immune response in rabbits, with -yM antibody activity first detected on Day 4, maximal on Day 6, and diminishing thereafter; in contrast, †̃yGactivity was detected

  2006cites this paper
• ImmunologicalAnalysisof A Strain Mice Bearingthe A-1OMammary Adenocarcinoma1

  2006cites this paper
• Cytogenetics of Mouse Leukemia L 1210 I . Association of a Specific Chromosome with Dihydrofolate Reductase Activity in Amethopterin-treated 2

  2006cites this paper
• Tumorigenicity of interleukin-2 (IL-2)-cDNA-transfected L1210 lymphoma and its in vivo variants is modulated by changes in IL-2 expression; potential therapeutic implications

  2005cites this paper
• Animal models of acute myelogenous leukaemia – development, application and future perspectives

  2005cites this paper
• Are syngeneic mouse tumor models still valuable experimental models in the field of anti-cancer drug discovery?

  2005cites this paper
• Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 1330

  2004cites this paper
• In vitro cytotoxic activity of lithotripter shock waves combined with Adriamycin or with cisplatin on L1210 mouse leukemia cells

  2004cites this paper
• Activation of a CPP32-like protease during L1210 cell apoptosis induced by thiol deprivation

  2004cites this paper
• Cellular pharmacology of the novel antitumoural cyanoguanidine CHS 828.

  2004cites this paper
• Discovery and Preclinical Antitumor Efficacy Evaluations of LY32262 and LY33169

  2003cites this paper
• Hypoxia increases cell death in multidrug-resistant leukemia cells. Differences in viability and ultrastructure between sensitive and multidrug-resistant L1210 mouse leukemic cells under hypoxia.

  2003cites this paper
• Optimization of cellular nucleotide extraction and sample preparation for nucleotide pool analyses using capillary electrophoresis.

  2003cites this paper
• Perspective on the History of Tumor Models

  2002cites this paper
• Transplantable Syngeneic Rodent Tumors

  2002cites this paper
• In Vivo Tumor Response End Points

  2002cites this paper
• Tissue distribution of GAP1(IP4BP) and GAP1(m): two inositol 1,3,4,5-tetrakisphosphate-binding proteins.

  2001cites this paper
• Tissue distribution of GAP1IP4BP and GAP1m

  2001cites this paper
• In vitro and in vivo antitumor activity of YoshixolTR against murine L1210 leukemic cells.

  1999cites this paper
• Selected nuclear LINE elements with mitochondrial‐DNA‐like inserts are more plentiful and mobile in tumor than in normal tissue of mouse and rat

  1998cites this paper
• Transmissibility of murine stem cell virus-based retroviral vectors carrying both interleukin-12 cDNAs and a third gene: implications for immune gene therapy.

  1997cites this paper
• Drug development in solid tumors: personal perspective of Dr. Emil J Freireich's contributions.

  1997cites this paper
• Single-chain Fv/folate conjugates mediate efficient lysis of folate-receptor-positive tumor cells.

  1997cites this paper
• HYPERSENSITIVITY TO CISPLATIN IN MOUSE LEUKEMIA L1210/0 CELLS: AN XPG DNA REPAIR DEFECT

  1996cites this paper
• Conjugates of folate and anti-T-cell-receptor antibodies specifically target folate-receptor-positive tumor cells for lysis.

  1995cites this paper
• An XPG DNA repair defect causing mutagen hypersensitivity in mouse leukemia L1210 cells

  1995cites this paper
• Reduced cavitation-induced cellular damage by the antioxidative effect of vitamin E.

  1994cites this paper
• In vivo models of P-glycoprotein-mediated multidrug resistance.

  1994cites this paper
• Thyroid hormone responsiveness of the L1210 murine leukemia cell line.

  1992cites this paper
• Cavitation-generated free radicals during shock wave exposure: investigations with cell-free solutions and suspended cells.

  1991cites this paper
• Distribution of homing protein on hemopoietic stromal and progenitor cells.

  1991cites this paper
• Therapeutic analysis of in vitro and in vivo brain tumor models.

  1991cites this paper
• Suppressive effect of adrenalectomy on growth of L1210 leukemic cells in ascites

  1990cites this paper
• Expansion by folinic acid of the peripheral blood progenitor pool after chemotherapy: its use in autografting in acute leukaemia

  1990cites this paper
• Inhibition of murine leukemia (WEHI-3B and L1210) proliferation by cholera toxin B subunit.

  1989cites this paper
• FUNCTIONAL STUDIES OF H‐2k‐LIKE EPITOPES ON DTIC TREATED AND UNTREATED L1210 (H‐2d) CLONES

  1989cites this paper
• Parallelism between transport inhibition and L1210 cell growth by ouabain.

  1988cites this paper
• Loss of tumorigenicity following in vitro MuLV infection is associated with induction of peritoneal natural killer cell activity.

  1988cites this paper
• Cytochemical characterization of mouse L1210 leukemia.

  1988cites this paper
• Host Defenses and Immunomodulation to Intracellular Pathogens

  1988cites this paper
• DTIC xenogenized lines obtained from an L1210 clone: clonal analysis of cytotoxic T lymphocyte reactivity.

  1988cites this paper
• Isolation of a colony-stimulating factor produced by L 1210 murine leukemia cells

  1987cites this paper
• Persulfide sulfur is a growth factor for cells defective in sulfur metabolism.

  1986cites this paper
• Clonal variation in tumorigenicity of L1210 lymphoma cells: nontumorigenic variants with an enhanced expression of tumor-associated antigen and Ia antigens.

  1986cites this paper
• Experiments evaluating antitumor immunity induced by cholesterol hemisuccinate‐treated syngeneic cell vaccines

  1986cites this paper
• Banding karyotype analysis of murine leukemia L1210 cell lines with special regard to changes associated with a shift from in vivo to in vitro growth.

  1985cites this paper
• Modulation of EL-4 mouse lymphoma cell proliferation by macrophages and tumor related factors

  1984cites this paper
• Interactions between clinically effective antitumor drugs and radiation in experimental systems.

  1984cites this paper
• Current NCI preclinical antitumor screening in vivo: results of tumor panel screening, 1976-1982, and future directions.

  1984cites this paper
• The chromosomes of L1210 mouse leukemia cells: G-banding, C-banding, and Ag-staining.

  1984cites this paper
• Properties of mouse leukemia viruses. XIX. Effective antibody therapy of AKR leukemia occurs independently of virus neutralization and produces long-term changes in the virus status of the thymus.

  1984cites this paper
• Effect of cell-substrate interaction time and shearing force on adhesion of L1210 cells to collagen and glass.

  1984cites this paper
• Isolation and characterization of subclones of L1210 murine leukemia with different sensitivities to various cytotoxic agents.

  1983cites this paper
• Hemin stimulating effect on colony formation of leukemic and bone marrow cells.

  1983cites this paper
• A Review of Animal Brain Tumor Models that have been used for Therapeutic Studies

  1983cites this paper
• Antineoplastic effects of N6-(delta 2-isopentenyl)adenosine against L-1210 mouse lymphocytic leukemic cells using a polymeric delivery system.

  1982cites this paper
• Cells of some cultured lymphoma lines are killed rapidly by x-rays and by bleomycin.

  1982cites this paper